Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
non-Hodgkin lymphoma
Pharma
FDA spotlights timely cancer accelerated approval confirmation
The FDA wants to hear cancer experts' opinions on two dangling accelerated approvals and ways to facilitate timely completion of confirmatory trials.
Angus Liu
Nov 15, 2023 8:20am
Abbvie, J&J pull 2 Imbruvica accelerated approvals
Apr 7, 2023 10:25am
Lilly wins FDA approval for 4th BTK blood cancer drug
Jan 27, 2023 3:50pm
ASH: Roche braces for lymphoma bispecific war
Dec 11, 2022 6:30pm
Pfizer gains its fourth FDA approval for an ALK-positive tumors
Jul 15, 2022 10:49am
Roche eyes year-end FDA bispecific verdict in lymphoma
Jul 6, 2022 10:15am